Ouro Medicines
Pre-clinicalOuro Medicines is a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases.
Founded
2021
Focus
AntibodiesBiologics
About
Ouro Medicines is a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases.
Funding History
1Total raised: $10M
Seed$10MMPM CapitalJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile